Article
The metabolomics of asthma control: a promising link between genetics and disease
7 May 2015
Abstract excerpt
Short-acting β agonists (e.g., albuterol) are the most commonly used medications for asthma, a disease that affects over 300 million people in the world. Metabolomic profiling of asthmatics taking β agonists presents a new and promising resource for identifying the molecular determinants of asthma control. The objective is to identify novel genetic and biochemical predictors of asthma control using an integrative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
